These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11331054

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S, Maeder MT, Toggweiler S, Rickli H, Nietlispach F, Julius B, Burkard T, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF Investigators.
    Am J Cardiol; 2012 Mar 01; 109(5):693-8. PubMed ID: 22152974
    [Abstract] [Full Text] [Related]

  • 29. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 30. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N, Kalaitzidis R, Bakris GL.
    Am J Nephrol; 2009 Dec 07; 30(5):418-24. PubMed ID: 19738369
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety of spironolactone use in ambulatory heart failure patients.
    Lopes RJ, Lourenço AP, Mascarenhas J, Azevedo A, Bettencourt P.
    Clin Cardiol; 2008 Nov 07; 31(11):509-13. PubMed ID: 19006114
    [Abstract] [Full Text] [Related]

  • 37. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).
    Pitt D.
    Eur Heart J; 1995 Dec 07; 16 Suppl N():107-10. PubMed ID: 8682055
    [Abstract] [Full Text] [Related]

  • 38. The effect of low-dose spironolactone on resistant hypertension.
    Engbaek M, Hjerrild M, Hallas J, Jacobsen IA.
    J Am Soc Hypertens; 2010 Dec 07; 4(6):290-4. PubMed ID: 21130975
    [Abstract] [Full Text] [Related]

  • 39. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S.
    BMJ; 2004 Aug 21; 329(7463):420. PubMed ID: 15321896
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.